ProQR Therapeutics
PRQR
#8914
Rank
โ‚ฌ0.12 B
Marketcap
1,19ย โ‚ฌ
Share price
-8.67%
Change (1 day)
-8.18%
Change (1 year)

Revenue for ProQR Therapeutics (PRQR)

Revenue in 2025 (TTM): โ‚ฌ15.52 Million

According to ProQR Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ14.95 Million. In 2024 the company made a revenue of โ‚ฌ18.9 Million an increase over the revenue in the year 2023 that were of โ‚ฌ6.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ProQR Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ15.52 M-17.88%
2024 โ‚ฌ18.9 M190.22%
2023 โ‚ฌ6.51 M76.24%
2022 โ‚ฌ3.69 M172.97%
2021 โ‚ฌ1.35 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Atara Biotherapeutics
ATRA
โ‚ฌ0.13 B 780.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ92.61 M 519.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Actinium Pharmaceuticals
ATNM
โ‚ฌ0.07 M-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA